You are here: Home: PCUTT1 | 2007: Treatment of Metastatic Prostate Cancer - Select Publications

SELECT PUBLICATIONS

Sternberg CN et al. Satraplatin (S) demonstrates significant clinical benefits for the treatment of patients with HRPC: Results of a randomized phase III trial. Proc ASCO 2007;Abstract 5019.

Tannock IF et al; TAX 327 Investigators. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351(15):1502-12. Abstract

 

Home